NKT lymphocyte polarization determined by microenvironment signaling : A role for CD8⁺ lymphocytes and β-glycosphingolipidsZIGMOND, Ehud; SHALEV, Zvi; PAPPO, Orit et al.Journal of autoimmunity (Print). 2008, Vol 31, Num 2, pp 188-195, issn 0896-8411, 8 p.Article

α-Galactosylceramide: NKT cell-based immunotherapy in intractable infectious diseasesKINJO, Yuki; KAWAKAMI, Kazuyoshi.Immunomodulators as promising therapeutic agents against infectiois diseases 2004. 2004, pp 105-122, isbn 81-7736-174-0, 18 p.Book Chapter

Vα14 NKT cell-mediated anti-tumor responses and their clinical applicationSEINO, Ken-Ichiro; FUJII, Shin-Ichiro; HARADA, Michishige et al.Springer seminars in immunopathology. 2005, Vol 27, Num 1, pp 65-74, issn 0344-4325, 10 p.Article

Ex vivo expansion of CD8⁺CD56⁺ and CD8⁺CD56^- natural killer T cells specific for MUC1 mucinWAJCHMAN, Howard J; PIERCE, Carl W; VARMA, Vijay A et al.Cancer research (Baltimore). 2004, Vol 64, Num 3, pp 1171-1180, issn 0008-5472, 10 p.Article

Clinical applications of natural killer T cell-based immunotherapy for cancerMOTOHASHI, Shinichiro; NAKAYAMA, Toshinori.Cancer science. 2008, Vol 99, Num 4, pp 638-645, issn 1347-9032, 8 p.Article

The immunoregulatory role of CD1d-restricted natural killer T cells in diseaseVAN DER VLIET, Hans J. J; MOLLING, Johan W; VON BLOMBERG, B. Mary E et al.Clinical immunology (Orlando, Fla. Print). 2004, Vol 112, Num 1, pp 8-23, issn 1521-6616, 16 p.Article

Sulfatide-Reactive Natural Killer T Cells Abrogate Ischemia-Reperfusion InjurySEUNG HEE YANG; JUNG PYO LEE; HYE RYOUN JANG et al.Journal of the American Society of Nephrology. 2011, Vol 22, Num 7, pp 1305-1314, issn 1046-6673, 10 p.Article

Innate immune responses support adaptive immunity: NKT cells induce B cell activationGALLI, Grazia; NUTI, Sandra; TAVARINI, Simona et al.Vaccine. Supplement. 2003, Vol 21, pp S2.48-S2.54, issn 1359-5938, 2Article

Natural killer T cells : A bridge to tolerance or a pathway to rejection?JUKES, John-Paul; WOOD, Kathryn J; JONES, Nick D et al.Transplantation. 2007, Vol 84, Num 6, pp 679-681, issn 0041-1337, 3 p.Article

Optimization of Natural Killer T Cell-Mediated Immunotherapy in Cancer Using Cell-Based and Nanovector VaccinesFAVEEUW, C; TROTTEIN, F.Cancer research (Chicago, Ill.). 2014, Vol 74, Num 6, pp 1632-1638, issn 0008-5472, 7 p.Article

Agonist Antibodies to TNFR Molecules That Costimulate T and NK CellsMELERO, Ignacio; HIRSCHHORN-CYMERMAN, Daniel; MORALES-KASTRESANA, Aizea et al.Clinical cancer research (Print). 2013, Vol 19, Num 5, pp 1044-1053, issn 1078-0432, 10 p.Article

Effects of cyclosporin A on the activation of natural killer T cells induced by α-galactosylceramideKAJIWARA, Takashi; TOTNITA, Yukihiro; OKANO, Shinji et al.Transplantation. 2007, Vol 83, Num 2, pp 184-192, issn 0041-1337, 9 p.Article

Negative modulation of invariant natural killer T cell responses to glycolipid antigens by p38 MAP kinaseSTUART, Jason K; BISCH, Steven P; LEON-PONTE, Matilde et al.International immunopharmacology (Print). 2010, Vol 10, Num 9, pp 1068-1076, issn 1567-5769, 9 p.Article

Developing understanding of the roles of CD1d-restricted T cell subsets in cancer: Reversing tumor-induced defects : Natural Killer T-cell-based ImmunotherapyEXLEY, Mark A; LYNCH, Lydia; VARGHESE, Bindu et al.Clinical immunology (Orlando, Fla. Print). 2011, Vol 140, Num 2, pp 184-195, issn 1521-6616, 12 p.Article

Human invariant natural killer T cells: implications for immunotherapyTAKAHASHI, Tsuyoshi; KUROKAWA, Mineo.International journal of hematology. 2009, Vol 90, Num 2, pp 137-142, issn 0925-5710, 6 p.Article

Invariant natural killer (iNK) T cell deficiency in patients with common variable immunodeficiencyFULCHER, D. A; AVERY, D. T; FEWINGS, N. L et al.Clinical and experimental immunology (Print). 2009, Vol 157, Num 3, pp 365-369, issn 0009-9104, 5 p.Article

Immunology in the Clinic Review Series; focus on host responses: invariant natural killer T cell activation following transplantationJUKES, J.-P; JONES, N. D.Clinical and experimental immunology (Print). 2012, Vol 167, Num 1, pp 32-39, issn 0009-9104, 8 p.Article

Molecular basis of lipid antigen presentation by CD1d and recognition by natural killer T cellsGIRARDI, Enrico; ZAJONC, Dirk M.Immunological reviews. 2012, Vol 250, pp 167-179, issn 0105-2896, 13 p.Article

A Novel Approach Inducing Transplant Tolerance by Activated Invariant Natural Killer T Cells With Costimulatory BlockadeHIRAI, T; ISHII, Y; IKEMIYAGI, M et al.American journal of transplantation (Print). 2014, Vol 14, Num 3, pp 554-567, issn 1600-6135, 14 p.Article

Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramideHOGAN, Andrew E; O'REILLY, Vincent; XIANGMING ZHU et al.Clinical immunology (Orlando, Fla. Print). 2011, Vol 140, Num 2, pp 196-207, issn 1521-6616, 12 p.Article

Invariant Natural Killer T Cells in Immune Surveillance and Tumor Immunotherapy : Perspectives and PotentialsMANSOUR HAERYFAR, S. M.Archives of Iranian medicine. 2008, Vol 11, Num 2, pp 186-195, 10 p.Article

Invariant natural killer T cells from children with versus without food allergy exhibit differential responsiveness to milk-derived sphingomyelinJYONOUCHI, Soma; ABRAHAM, Valsamma; ORANGE, Jordan S et al.Journal of allergy and clinical immunology. 2011, Vol 128, Num 1, pp 102-109, issn 0091-6749, 8 p.Article

An expanding role for apolipoprotein E in sepsis and inflammationCHUANG, Kelley; ELFORD, Erica L; TSENG, Jill et al.The American journal of surgery. 2010, Vol 200, Num 3, pp 391-397, issn 0002-9610, 7 p.Article

Carbohydrate specificity of the recognition of diverse glycolipids by natural killer T cellsZAJONC, Dirk M; KRONENBERG, Mitchell.Immunological reviews. 2009, Vol 230, pp 188-200, issn 0105-2896, 13 p.Article

Views of immunology: effector T cellsLEWINSOHN, Deborah A; GOLD, Marielle C; LEWINSOHN, David M et al.Immunological reviews. 2011, Vol 240, pp 25-39, issn 0105-2896, 15 p.Article